Compare UTHR & SFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UTHR | SFM |
|---|---|---|
| Founded | 1996 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Food Chains |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.3B | 10.9B |
| IPO Year | 1999 | 2013 |
| Metric | UTHR | SFM |
|---|---|---|
| Price | $488.92 | $85.26 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 14 |
| Target Price | ★ $495.08 | $138.64 |
| AVG Volume (30 Days) | 424.3K | ★ 2.2M |
| Earning Date | 10-29-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 16.08 | ★ 49.03 |
| EPS | ★ 26.38 | 5.15 |
| Revenue | $3,128,400,000.00 | ★ $8,653,696,000.00 |
| Revenue This Year | $13.64 | $15.28 |
| Revenue Next Year | $5.78 | $9.86 |
| P/E Ratio | $18.55 | ★ $16.61 |
| Revenue Growth | 13.50 | ★ 16.60 |
| 52 Week Low | $266.98 | $75.75 |
| 52 Week High | $492.62 | $182.00 |
| Indicator | UTHR | SFM |
|---|---|---|
| Relative Strength Index (RSI) | 68.10 | 46.56 |
| Support Level | $470.13 | $84.10 |
| Resistance Level | $492.62 | $86.69 |
| Average True Range (ATR) | 10.72 | 2.48 |
| MACD | -0.53 | 1.63 |
| Stochastic Oscillator | 89.55 | 79.65 |
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.
Sprouts Farmers Market Inc offers a specialty grocery experience featuring an open layout with fresh produce at the heart of the store. Sprouts inspire wellness naturally with a carefully curated assortment products paired with purpose-driven people. The company continues to bring products made with lifestyle-friendly ingredients such as organic, plant-based, and gluten-free. It approximately has 407 stores in nearly 23 states. The Company has one operating segment that is healthy grocery stores.